Business Context and Reporting Period
Fresenius Medical Care AG & Co. KGaA filed Form 6-K on June 2, 2023, reporting unaudited full-year results for the year ended December 31, 2022, and quarterly results for all four quarters of 2022. The Company implemented a new global operating model effective January 1, 2023, reorganizing its business into two segments: Care Delivery and Care Enablement.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It confirms the use of non-GAAP financial measures including EBITDA, free cash flow, and net leverage ratio, alongside IFRS results. Detailed figures are contained in the attached Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The primary material change is the restructuring of the Company's reporting structure into two global operating segments (Care Delivery and Care Enablement) effective January 1, 2023. This realignment affects the presentation of quarterly and full-year results to ensure consistency and comparability with prior periods using non-GAAP measures.
Guidance, Outlook, and Risks
The filing text does not contain specific forward-looking guidance, management commentary on future performance, or a detailed list of risks and contingencies. It notes that non-GAAP measures are provided to enhance understanding of current performance and future prospects but should not substitute for GAAP measures. Reconciliations between non-GAAP and IFRS measures are included in the attached financial statements.
Investor Verification Checklist
- Verify specific revenue, EBITDA, and free cash flow figures in Exhibit 99.1, as they are not present in the cover letter text.
- Review the reconciliation tables to understand the adjustments made to derive non-GAAP measures from IFRS results.
- Confirm the impact of the new operating model (Care Delivery vs. Care Enablement) on segment-specific performance.
- Check for any special items or constant currency adjustments detailed in the attached financial tables.